Neurology News

A novel 3D video imaging tool has shown high potential for the use of real-time classification of epileptic seizures in hospitals, researchers reported in Scientific Reports.

Migraine has a bidirectional relationship with mental disorders such as anxiety and depression, and one may increase the risk of the other, researchers reported in Cureus.

In patients with active secondary progressive MS, hematopoietic stem cell transplants may delay disability longer than some MS medications, researchers reported in Neurology.

Vistagen announced it has agreed to acquire Pherin Pharmaceuticals Inc., to bolster its efforts on discovery and development of therapeutics to treat a range of psychiatric and neuropsychiatric conditions.

There was insufficient evidence of excess harm associated with off-label IV thrombolysis in patients after ischemic stroke with recent intake of a direct oral anticoagulant, researchers reported in JAMA Neurology.

In other articles for Residency for Retirement, we have explained that permanent life insurance, also called cash value life insurance, has tremendous tax, wealth accumulation, asset protection and estate planning benefits.

Despite similar outcomes following endovascular thrombectomy anterior large vessel ischemic stroke, patients with osteoarthritis were 22.5% less likely to undergo EVT compared with those without it, researchers reported.

Xironetic has announced the FDA clearance of the IntraOpVSP software, which is an augmented reality visualization software for complex surgeries, according to a press release.

A congressional investigation found the FDA’s interactions with Biogen were “atypical and failed to follow” protocol and that the two “inappropriately collaborated” on documentation before the approval of Aduhelm for Alzheimer’s disease.

The blood-based measure of neurofilament light chain was associated with the presence of neuronal injury in those with peripheral neuropathy, according to a systematic review and meta-analysis in JAMA Network Open.